Rebrain
AI-assisted MRI targeting and surgical planning for neurosurgeons treating Parkinson’s disease and essential tremor
Highlights
- New on EvolcAdded 2026-10-30
About Rebrain
Rebrain provides a supervised AI-assisted targeting service for functional neurosurgery. Its OptimMRI and OptimDBS software process MRI data and return images with target overlays for deep brain stimulation planning.
The service is designed for neurosurgeons and clinical teams, integrating with their existing workflows through a secure health-data platform. The company is a spin-off of the University Hospital of Bordeaux and Inria, founded in 2021 and headquartered in Pessac, France.
Product: Supervised AI-assisted MRI targeting and planning software for functional neurosurgery, including OptimMRI and OptimDBS.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France, worth €12.0M as awarded. From EU award notices (TED) that name Rebrain by its registry number.
- 10 Mar 2025 RESAH · Prestation d'aide à l'identification des zones du cerveau à opérer pour les patients atteints de la maladie de Parkinson et tremblement essentiel via une solution innovante d'intelligence artificielle. · €12.0M notice
Jobs at Rebrain
Leadership
- David Caumartin · CEOSource: company website
- Emmanuel Cuny · Co-founder, CMO & Board PresidentSource: company website
- Nejib Zemzemi · Co-founder, CSO & CTOSource: company website
More health & medtech companies
Remedee Labs
Millimeter-wave neuromodulation wristbands and digital support for people with chronic painNew on EvolcResilience Care
Remote patient monitoring and real-world data platform for oncology, psychiatry and gastroenterology care teams and life sciences firmsNew on EvolcRemote-friendlyResoltive
Develops and manufactures hematology diagnostic instruments and reagents for OEM partnersNew on EvolcResolve Stroke
AI ultrasound imaging software and systems for clinicians monitoring neurological patients at the bedsideYoung companyNew on EvolcRetinov
At-home blood test measuring omega-3 levels in the retina, for patients with early age-related macular degenerationYoung companyNew on EvolcRobeaute
Develops rice-sized microrobots to diagnose, treat and monitor brain disease, aimed at neurosurgery
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Complianz
- Google reCAPTCHA
- PHP
- WooCommerce
- WordPress
- jQuery